K K Nakano, H Zubick, H R Tyler. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » 1-Propanol/therapeutic useAdultAgedAntiparkinson Agents/therapeutic useDihydroxyphenylalanine/therapeutic useEvaluation Studies as TopicFacial Muscles/drug effectsFacial Muscles/physiopathologyFemaleHumansLip/drug effectsMaleMiddle AgedParkinson Disease/complicationsParkinson Disease/drug therapyParkinson Disease/physiopathologyPlacebosProcyclidine/therapeutic usePyrrolidines/therapeutic useSpeech/drug effectsSpeech Disorders/drug therapySpeech Disorders/etiology
Substances: See more » Antiparkinson AgentsPlacebosPyrrolidinesDihydroxyphenylalanine1-PropanolProcyclidine
Year: 1973 PMID: 4737081 DOI: 10.1212/wnl.23.8.865
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910